ANN MED 润色咨询

ANNALS OF MEDICINE

出版年份：1989 年文章数：1571 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：2.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2270543, encodeId=cddf22e0543a3, content=偏重的研究方向：回顾性分析;临床研究;内科学<br>经验分享：第一次投中科院二区，5分左右的期刊。 2024月10月投稿 一审历时三个月 2025年1月左右revision required,结果是小修 返修回去两天直接接受accepted,没有再继续二审 接受后大概再两个月后缴费并收到proof 返回proof后四天见刊。总体还算顺利，审稿人提的修改意见也都蛮专业，确实能提高文章质量 这个期刊主要是技术审查比较严格，在投稿、返修、接受后都会进行严格的审查(大概会花个一两天)，包括对文章文本和图片进行查重，以及对研究内容的伦理方面的审查等。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aeb9014890, createdName=ms5000000025670923, createdTime=Mon Jun 23 15:48:24 CST 2025, time=2025-06-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2249814, encodeId=d0012249814cf, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：一审45天：小修，二审10天：小修，三审3天：接受，出版时间：1月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1f8485059, createdName=ms4000002141710869, createdTime=Mon Jan 27 23:41:24 CST 2025, time=2025-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2271446, encodeId=b5b522e144686, content=非常垃圾的杂志，恶意拖拉稿件，回修后3个月没有任何反应，催稿就拒稿，绝对垃圾中的战斗机，我同事Proof交钱后一样给你撤稿。浪费你1-2年不在话下。26 November 2024<br>Submission Created<br>26 November 2024<br>Submission Incomplete<br>26 November 2024<br>Manuscript Submitted<br>26 November 2024<br>With Journal Administrator<br>27 November 2024<br>Submission Returned to Author<br>28 November 2024<br>Submission Incomplete<br>28 November 2024<br>Manuscript Resubmitted<br>28 November 2024<br>With Journal Administrator<br>06 December 2024<br>With Editor<br>30 January 2025<br>Out for Review<br>29 March 2025<br>Decision Pending<br>29 March 2025<br>Revision Required<br>05 April 2025<br>Revision Incomplete<br>05 April 2025<br>Revised Manuscript Submitted<br>05 April 2025<br>With Journal Administrator<br>30 June 2025<br>Withdrawn, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Mon Jun 30 13:31:13 CST 2025, time=2025-06-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2271099, encodeId=addc22e109926, content=偏重的研究方向：临床研究<br>经验分享：杂志失联了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Fri Jun 27 13:24:26 CST 2025, time=2025-06-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2140147, encodeId=300c214014ee8, content=这个杂志查重放在哪一步啊目前处在修改格式的最初阶段🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Wed May 31 18:33:58 CST 2023, time=2023-05-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2219406, encodeId=6614221940646, content=偏重的研究方向：临床研究<br>经验分享：年刊中科院分区怎么算呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39e15555908, createdName=ms4000000190354659, createdTime=Sat Aug 10 17:09:45 CST 2024, time=2024-08-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220799, encodeId=53632220e99d0, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196b9426125, createdName=ms4000001726460894, createdTime=Sat Aug 17 13:31:35 CST 2024, time=2024-08-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究<br>经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2137722, encodeId=65b0213e72222, content=审稿速度:1.0<br>偏重的研究方向：感染<br>经验分享：当初通过Taylor & Francis Group投稿时杂志名称是 Annals of Medicine，但编辑后来发邮件修回时都显示的是“Annals of Medicine (Elevate)”，请问大家出现过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26ef8179690, createdName=ms7000001826758656, createdTime=Thu May 18 20:17:59 CST 2023, time=2023-05-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1241802, encodeId=f26f12418026c, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：第一次投这个期刊，感觉审稿速度很快，6月18号投，8月11号接到修改意见，23号就接收了，一切顺利的让人有些不可思议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fac5601213, createdName=ms1000000058940156, createdTime=Mon Aug 29 09:54:28 CST 2022, time=2022-08-29, status=1, ipAttribution=)]
    2025-06-23 ms5000000025670923 来自福建省

    偏重的研究方向：回顾性分析;临床研究;内科学
    经验分享：第一次投中科院二区，5分左右的期刊。 2024月10月投稿 一审历时三个月 2025年1月左右revision required,结果是小修 返修回去两天直接接受accepted,没有再继续二审 接受后大概再两个月后缴费并收到proof 返回proof后四天见刊。总体还算顺利，审稿人提的修改意见也都蛮专业，确实能提高文章质量 这个期刊主要是技术审查比较严格，在投稿、返修、接受后都会进行严格的审查(大概会花个一两天)，包括对文章文本和图片进行查重，以及对研究内容的伦理方面的审查等。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2270543, encodeId=cddf22e0543a3, content=偏重的研究方向：回顾性分析;临床研究;内科学<br>经验分享：第一次投中科院二区，5分左右的期刊。 2024月10月投稿 一审历时三个月 2025年1月左右revision required,结果是小修 返修回去两天直接接受accepted,没有再继续二审 接受后大概再两个月后缴费并收到proof 返回proof后四天见刊。总体还算顺利，审稿人提的修改意见也都蛮专业，确实能提高文章质量 这个期刊主要是技术审查比较严格，在投稿、返修、接受后都会进行严格的审查(大概会花个一两天)，包括对文章文本和图片进行查重，以及对研究内容的伦理方面的审查等。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aeb9014890, createdName=ms5000000025670923, createdTime=Mon Jun 23 15:48:24 CST 2025, time=2025-06-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2249814, encodeId=d0012249814cf, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：一审45天：小修，二审10天：小修，三审3天：接受，出版时间：1月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1f8485059, createdName=ms4000002141710869, createdTime=Mon Jan 27 23:41:24 CST 2025, time=2025-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2271446, encodeId=b5b522e144686, content=非常垃圾的杂志，恶意拖拉稿件，回修后3个月没有任何反应，催稿就拒稿，绝对垃圾中的战斗机，我同事Proof交钱后一样给你撤稿。浪费你1-2年不在话下。26 November 2024<br>Submission Created<br>26 November 2024<br>Submission Incomplete<br>26 November 2024<br>Manuscript Submitted<br>26 November 2024<br>With Journal Administrator<br>27 November 2024<br>Submission Returned to Author<br>28 November 2024<br>Submission Incomplete<br>28 November 2024<br>Manuscript Resubmitted<br>28 November 2024<br>With Journal Administrator<br>06 December 2024<br>With Editor<br>30 January 2025<br>Out for Review<br>29 March 2025<br>Decision Pending<br>29 March 2025<br>Revision Required<br>05 April 2025<br>Revision Incomplete<br>05 April 2025<br>Revised Manuscript Submitted<br>05 April 2025<br>With Journal Administrator<br>30 June 2025<br>Withdrawn, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Mon Jun 30 13:31:13 CST 2025, time=2025-06-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2271099, encodeId=addc22e109926, content=偏重的研究方向：临床研究<br>经验分享：杂志失联了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Fri Jun 27 13:24:26 CST 2025, time=2025-06-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2140147, encodeId=300c214014ee8, content=这个杂志查重放在哪一步啊目前处在修改格式的最初阶段🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Wed May 31 18:33:58 CST 2023, time=2023-05-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2219406, encodeId=6614221940646, content=偏重的研究方向：临床研究<br>经验分享：年刊中科院分区怎么算呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39e15555908, createdName=ms4000000190354659, createdTime=Sat Aug 10 17:09:45 CST 2024, time=2024-08-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220799, encodeId=53632220e99d0, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196b9426125, createdName=ms4000001726460894, createdTime=Sat Aug 17 13:31:35 CST 2024, time=2024-08-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究<br>经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2137722, encodeId=65b0213e72222, content=审稿速度:1.0<br>偏重的研究方向：感染<br>经验分享：当初通过Taylor & Francis Group投稿时杂志名称是 Annals of Medicine，但编辑后来发邮件修回时都显示的是“Annals of Medicine (Elevate)”，请问大家出现过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26ef8179690, createdName=ms7000001826758656, createdTime=Thu May 18 20:17:59 CST 2023, time=2023-05-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1241802, encodeId=f26f12418026c, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：第一次投这个期刊，感觉审稿速度很快，6月18号投，8月11号接到修改意见，23号就接收了，一切顺利的让人有些不可思议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fac5601213, createdName=ms1000000058940156, createdTime=Mon Aug 29 09:54:28 CST 2022, time=2022-08-29, status=1, ipAttribution=)]
    2025-01-27 ms4000002141710869 来自湖南省

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：一审45天：小修，二审10天：小修，三审3天：接受，出版时间：1月

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2270543, encodeId=cddf22e0543a3, content=偏重的研究方向：回顾性分析;临床研究;内科学<br>经验分享：第一次投中科院二区，5分左右的期刊。 2024月10月投稿 一审历时三个月 2025年1月左右revision required,结果是小修 返修回去两天直接接受accepted,没有再继续二审 接受后大概再两个月后缴费并收到proof 返回proof后四天见刊。总体还算顺利，审稿人提的修改意见也都蛮专业，确实能提高文章质量 这个期刊主要是技术审查比较严格，在投稿、返修、接受后都会进行严格的审查(大概会花个一两天)，包括对文章文本和图片进行查重，以及对研究内容的伦理方面的审查等。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aeb9014890, createdName=ms5000000025670923, createdTime=Mon Jun 23 15:48:24 CST 2025, time=2025-06-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2249814, encodeId=d0012249814cf, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：一审45天：小修，二审10天：小修，三审3天：接受，出版时间：1月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1f8485059, createdName=ms4000002141710869, createdTime=Mon Jan 27 23:41:24 CST 2025, time=2025-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2271446, encodeId=b5b522e144686, content=非常垃圾的杂志，恶意拖拉稿件，回修后3个月没有任何反应，催稿就拒稿，绝对垃圾中的战斗机，我同事Proof交钱后一样给你撤稿。浪费你1-2年不在话下。26 November 2024<br>Submission Created<br>26 November 2024<br>Submission Incomplete<br>26 November 2024<br>Manuscript Submitted<br>26 November 2024<br>With Journal Administrator<br>27 November 2024<br>Submission Returned to Author<br>28 November 2024<br>Submission Incomplete<br>28 November 2024<br>Manuscript Resubmitted<br>28 November 2024<br>With Journal Administrator<br>06 December 2024<br>With Editor<br>30 January 2025<br>Out for Review<br>29 March 2025<br>Decision Pending<br>29 March 2025<br>Revision Required<br>05 April 2025<br>Revision Incomplete<br>05 April 2025<br>Revised Manuscript Submitted<br>05 April 2025<br>With Journal Administrator<br>30 June 2025<br>Withdrawn, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Mon Jun 30 13:31:13 CST 2025, time=2025-06-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2271099, encodeId=addc22e109926, content=偏重的研究方向：临床研究<br>经验分享：杂志失联了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Fri Jun 27 13:24:26 CST 2025, time=2025-06-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2140147, encodeId=300c214014ee8, content=这个杂志查重放在哪一步啊目前处在修改格式的最初阶段🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Wed May 31 18:33:58 CST 2023, time=2023-05-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2219406, encodeId=6614221940646, content=偏重的研究方向：临床研究<br>经验分享：年刊中科院分区怎么算呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39e15555908, createdName=ms4000000190354659, createdTime=Sat Aug 10 17:09:45 CST 2024, time=2024-08-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220799, encodeId=53632220e99d0, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196b9426125, createdName=ms4000001726460894, createdTime=Sat Aug 17 13:31:35 CST 2024, time=2024-08-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究<br>经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2137722, encodeId=65b0213e72222, content=审稿速度:1.0<br>偏重的研究方向：感染<br>经验分享：当初通过Taylor & Francis Group投稿时杂志名称是 Annals of Medicine，但编辑后来发邮件修回时都显示的是“Annals of Medicine (Elevate)”，请问大家出现过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26ef8179690, createdName=ms7000001826758656, createdTime=Thu May 18 20:17:59 CST 2023, time=2023-05-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1241802, encodeId=f26f12418026c, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：第一次投这个期刊，感觉审稿速度很快，6月18号投，8月11号接到修改意见，23号就接收了，一切顺利的让人有些不可思议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fac5601213, createdName=ms1000000058940156, createdTime=Mon Aug 29 09:54:28 CST 2022, time=2022-08-29, status=1, ipAttribution=)]
    2025-06-30 1de4308em68(暂无匿称) 来自浙江省

    非常垃圾的杂志，恶意拖拉稿件，回修后3个月没有任何反应，催稿就拒稿，绝对垃圾中的战斗机，我同事Proof交钱后一样给你撤稿。浪费你1-2年不在话下。26 November 2024
    Submission Created
    26 November 2024
    Submission Incomplete
    26 November 2024
    Manuscript Submitted
    26 November 2024
    With Journal Administrator
    27 November 2024
    Submission Returned to Author
    28 November 2024
    Submission Incomplete
    28 November 2024
    Manuscript Resubmitted
    28 November 2024
    With Journal Administrator
    06 December 2024
    With Editor
    30 January 2025
    Out for Review
    29 March 2025
    Decision Pending
    29 March 2025
    Revision Required
    05 April 2025
    Revision Incomplete
    05 April 2025
    Revised Manuscript Submitted
    05 April 2025
    With Journal Administrator
    30 June 2025
    Withdrawn

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2270543, encodeId=cddf22e0543a3, content=偏重的研究方向：回顾性分析;临床研究;内科学<br>经验分享：第一次投中科院二区，5分左右的期刊。 2024月10月投稿 一审历时三个月 2025年1月左右revision required,结果是小修 返修回去两天直接接受accepted,没有再继续二审 接受后大概再两个月后缴费并收到proof 返回proof后四天见刊。总体还算顺利，审稿人提的修改意见也都蛮专业，确实能提高文章质量 这个期刊主要是技术审查比较严格，在投稿、返修、接受后都会进行严格的审查(大概会花个一两天)，包括对文章文本和图片进行查重，以及对研究内容的伦理方面的审查等。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aeb9014890, createdName=ms5000000025670923, createdTime=Mon Jun 23 15:48:24 CST 2025, time=2025-06-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2249814, encodeId=d0012249814cf, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：一审45天：小修，二审10天：小修，三审3天：接受，出版时间：1月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1f8485059, createdName=ms4000002141710869, createdTime=Mon Jan 27 23:41:24 CST 2025, time=2025-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2271446, encodeId=b5b522e144686, content=非常垃圾的杂志，恶意拖拉稿件，回修后3个月没有任何反应，催稿就拒稿，绝对垃圾中的战斗机，我同事Proof交钱后一样给你撤稿。浪费你1-2年不在话下。26 November 2024<br>Submission Created<br>26 November 2024<br>Submission Incomplete<br>26 November 2024<br>Manuscript Submitted<br>26 November 2024<br>With Journal Administrator<br>27 November 2024<br>Submission Returned to Author<br>28 November 2024<br>Submission Incomplete<br>28 November 2024<br>Manuscript Resubmitted<br>28 November 2024<br>With Journal Administrator<br>06 December 2024<br>With Editor<br>30 January 2025<br>Out for Review<br>29 March 2025<br>Decision Pending<br>29 March 2025<br>Revision Required<br>05 April 2025<br>Revision Incomplete<br>05 April 2025<br>Revised Manuscript Submitted<br>05 April 2025<br>With Journal Administrator<br>30 June 2025<br>Withdrawn, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Mon Jun 30 13:31:13 CST 2025, time=2025-06-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2271099, encodeId=addc22e109926, content=偏重的研究方向：临床研究<br>经验分享：杂志失联了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Fri Jun 27 13:24:26 CST 2025, time=2025-06-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2140147, encodeId=300c214014ee8, content=这个杂志查重放在哪一步啊目前处在修改格式的最初阶段🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Wed May 31 18:33:58 CST 2023, time=2023-05-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2219406, encodeId=6614221940646, content=偏重的研究方向：临床研究<br>经验分享：年刊中科院分区怎么算呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39e15555908, createdName=ms4000000190354659, createdTime=Sat Aug 10 17:09:45 CST 2024, time=2024-08-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220799, encodeId=53632220e99d0, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196b9426125, createdName=ms4000001726460894, createdTime=Sat Aug 17 13:31:35 CST 2024, time=2024-08-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究<br>经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2137722, encodeId=65b0213e72222, content=审稿速度:1.0<br>偏重的研究方向：感染<br>经验分享：当初通过Taylor & Francis Group投稿时杂志名称是 Annals of Medicine，但编辑后来发邮件修回时都显示的是“Annals of Medicine (Elevate)”，请问大家出现过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26ef8179690, createdName=ms7000001826758656, createdTime=Thu May 18 20:17:59 CST 2023, time=2023-05-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1241802, encodeId=f26f12418026c, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：第一次投这个期刊，感觉审稿速度很快，6月18号投，8月11号接到修改意见，23号就接收了，一切顺利的让人有些不可思议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fac5601213, createdName=ms1000000058940156, createdTime=Mon Aug 29 09:54:28 CST 2022, time=2022-08-29, status=1, ipAttribution=)]
    2025-06-27 14891788m58(暂无昵称) 来自云南省

    偏重的研究方向：临床研究
    经验分享：杂志失联了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2270543, encodeId=cddf22e0543a3, content=偏重的研究方向：回顾性分析;临床研究;内科学<br>经验分享：第一次投中科院二区，5分左右的期刊。 2024月10月投稿 一审历时三个月 2025年1月左右revision required,结果是小修 返修回去两天直接接受accepted,没有再继续二审 接受后大概再两个月后缴费并收到proof 返回proof后四天见刊。总体还算顺利，审稿人提的修改意见也都蛮专业，确实能提高文章质量 这个期刊主要是技术审查比较严格，在投稿、返修、接受后都会进行严格的审查(大概会花个一两天)，包括对文章文本和图片进行查重，以及对研究内容的伦理方面的审查等。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aeb9014890, createdName=ms5000000025670923, createdTime=Mon Jun 23 15:48:24 CST 2025, time=2025-06-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2249814, encodeId=d0012249814cf, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：一审45天：小修，二审10天：小修，三审3天：接受，出版时间：1月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1f8485059, createdName=ms4000002141710869, createdTime=Mon Jan 27 23:41:24 CST 2025, time=2025-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2271446, encodeId=b5b522e144686, content=非常垃圾的杂志，恶意拖拉稿件，回修后3个月没有任何反应，催稿就拒稿，绝对垃圾中的战斗机，我同事Proof交钱后一样给你撤稿。浪费你1-2年不在话下。26 November 2024<br>Submission Created<br>26 November 2024<br>Submission Incomplete<br>26 November 2024<br>Manuscript Submitted<br>26 November 2024<br>With Journal Administrator<br>27 November 2024<br>Submission Returned to Author<br>28 November 2024<br>Submission Incomplete<br>28 November 2024<br>Manuscript Resubmitted<br>28 November 2024<br>With Journal Administrator<br>06 December 2024<br>With Editor<br>30 January 2025<br>Out for Review<br>29 March 2025<br>Decision Pending<br>29 March 2025<br>Revision Required<br>05 April 2025<br>Revision Incomplete<br>05 April 2025<br>Revised Manuscript Submitted<br>05 April 2025<br>With Journal Administrator<br>30 June 2025<br>Withdrawn, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Mon Jun 30 13:31:13 CST 2025, time=2025-06-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2271099, encodeId=addc22e109926, content=偏重的研究方向：临床研究<br>经验分享：杂志失联了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Fri Jun 27 13:24:26 CST 2025, time=2025-06-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2140147, encodeId=300c214014ee8, content=这个杂志查重放在哪一步啊目前处在修改格式的最初阶段🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Wed May 31 18:33:58 CST 2023, time=2023-05-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2219406, encodeId=6614221940646, content=偏重的研究方向：临床研究<br>经验分享：年刊中科院分区怎么算呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39e15555908, createdName=ms4000000190354659, createdTime=Sat Aug 10 17:09:45 CST 2024, time=2024-08-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220799, encodeId=53632220e99d0, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196b9426125, createdName=ms4000001726460894, createdTime=Sat Aug 17 13:31:35 CST 2024, time=2024-08-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究<br>经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2137722, encodeId=65b0213e72222, content=审稿速度:1.0<br>偏重的研究方向：感染<br>经验分享：当初通过Taylor & Francis Group投稿时杂志名称是 Annals of Medicine，但编辑后来发邮件修回时都显示的是“Annals of Medicine (Elevate)”，请问大家出现过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26ef8179690, createdName=ms7000001826758656, createdTime=Thu May 18 20:17:59 CST 2023, time=2023-05-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1241802, encodeId=f26f12418026c, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：第一次投这个期刊，感觉审稿速度很快，6月18号投，8月11号接到修改意见，23号就接收了，一切顺利的让人有些不可思议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fac5601213, createdName=ms1000000058940156, createdTime=Mon Aug 29 09:54:28 CST 2022, time=2022-08-29, status=1, ipAttribution=)]
    2023-05-31 ms8000001764716829 来自山西省

    这个杂志查重放在哪一步啊目前处在修改格式的最初阶段🥹

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2270543, encodeId=cddf22e0543a3, content=偏重的研究方向：回顾性分析;临床研究;内科学<br>经验分享：第一次投中科院二区，5分左右的期刊。 2024月10月投稿 一审历时三个月 2025年1月左右revision required,结果是小修 返修回去两天直接接受accepted,没有再继续二审 接受后大概再两个月后缴费并收到proof 返回proof后四天见刊。总体还算顺利，审稿人提的修改意见也都蛮专业，确实能提高文章质量 这个期刊主要是技术审查比较严格，在投稿、返修、接受后都会进行严格的审查(大概会花个一两天)，包括对文章文本和图片进行查重，以及对研究内容的伦理方面的审查等。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aeb9014890, createdName=ms5000000025670923, createdTime=Mon Jun 23 15:48:24 CST 2025, time=2025-06-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2249814, encodeId=d0012249814cf, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：一审45天：小修，二审10天：小修，三审3天：接受，出版时间：1月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1f8485059, createdName=ms4000002141710869, createdTime=Mon Jan 27 23:41:24 CST 2025, time=2025-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2271446, encodeId=b5b522e144686, content=非常垃圾的杂志，恶意拖拉稿件，回修后3个月没有任何反应，催稿就拒稿，绝对垃圾中的战斗机，我同事Proof交钱后一样给你撤稿。浪费你1-2年不在话下。26 November 2024<br>Submission Created<br>26 November 2024<br>Submission Incomplete<br>26 November 2024<br>Manuscript Submitted<br>26 November 2024<br>With Journal Administrator<br>27 November 2024<br>Submission Returned to Author<br>28 November 2024<br>Submission Incomplete<br>28 November 2024<br>Manuscript Resubmitted<br>28 November 2024<br>With Journal Administrator<br>06 December 2024<br>With Editor<br>30 January 2025<br>Out for Review<br>29 March 2025<br>Decision Pending<br>29 March 2025<br>Revision Required<br>05 April 2025<br>Revision Incomplete<br>05 April 2025<br>Revised Manuscript Submitted<br>05 April 2025<br>With Journal Administrator<br>30 June 2025<br>Withdrawn, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Mon Jun 30 13:31:13 CST 2025, time=2025-06-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2271099, encodeId=addc22e109926, content=偏重的研究方向：临床研究<br>经验分享：杂志失联了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Fri Jun 27 13:24:26 CST 2025, time=2025-06-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2140147, encodeId=300c214014ee8, content=这个杂志查重放在哪一步啊目前处在修改格式的最初阶段🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Wed May 31 18:33:58 CST 2023, time=2023-05-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2219406, encodeId=6614221940646, content=偏重的研究方向：临床研究<br>经验分享：年刊中科院分区怎么算呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39e15555908, createdName=ms4000000190354659, createdTime=Sat Aug 10 17:09:45 CST 2024, time=2024-08-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220799, encodeId=53632220e99d0, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196b9426125, createdName=ms4000001726460894, createdTime=Sat Aug 17 13:31:35 CST 2024, time=2024-08-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究<br>经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2137722, encodeId=65b0213e72222, content=审稿速度:1.0<br>偏重的研究方向：感染<br>经验分享：当初通过Taylor & Francis Group投稿时杂志名称是 Annals of Medicine，但编辑后来发邮件修回时都显示的是“Annals of Medicine (Elevate)”，请问大家出现过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26ef8179690, createdName=ms7000001826758656, createdTime=Thu May 18 20:17:59 CST 2023, time=2023-05-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1241802, encodeId=f26f12418026c, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：第一次投这个期刊，感觉审稿速度很快，6月18号投，8月11号接到修改意见，23号就接收了，一切顺利的让人有些不可思议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fac5601213, createdName=ms1000000058940156, createdTime=Mon Aug 29 09:54:28 CST 2022, time=2022-08-29, status=1, ipAttribution=)]
    2024-08-10 ms4000000190354659 来自山东省

    偏重的研究方向：临床研究
    经验分享：年刊中科院分区怎么算呢？

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2270543, encodeId=cddf22e0543a3, content=偏重的研究方向：回顾性分析;临床研究;内科学<br>经验分享：第一次投中科院二区，5分左右的期刊。 2024月10月投稿 一审历时三个月 2025年1月左右revision required,结果是小修 返修回去两天直接接受accepted,没有再继续二审 接受后大概再两个月后缴费并收到proof 返回proof后四天见刊。总体还算顺利，审稿人提的修改意见也都蛮专业，确实能提高文章质量 这个期刊主要是技术审查比较严格，在投稿、返修、接受后都会进行严格的审查(大概会花个一两天)，包括对文章文本和图片进行查重，以及对研究内容的伦理方面的审查等。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aeb9014890, createdName=ms5000000025670923, createdTime=Mon Jun 23 15:48:24 CST 2025, time=2025-06-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2249814, encodeId=d0012249814cf, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：一审45天：小修，二审10天：小修，三审3天：接受，出版时间：1月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1f8485059, createdName=ms4000002141710869, createdTime=Mon Jan 27 23:41:24 CST 2025, time=2025-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2271446, encodeId=b5b522e144686, content=非常垃圾的杂志，恶意拖拉稿件，回修后3个月没有任何反应，催稿就拒稿，绝对垃圾中的战斗机，我同事Proof交钱后一样给你撤稿。浪费你1-2年不在话下。26 November 2024<br>Submission Created<br>26 November 2024<br>Submission Incomplete<br>26 November 2024<br>Manuscript Submitted<br>26 November 2024<br>With Journal Administrator<br>27 November 2024<br>Submission Returned to Author<br>28 November 2024<br>Submission Incomplete<br>28 November 2024<br>Manuscript Resubmitted<br>28 November 2024<br>With Journal Administrator<br>06 December 2024<br>With Editor<br>30 January 2025<br>Out for Review<br>29 March 2025<br>Decision Pending<br>29 March 2025<br>Revision Required<br>05 April 2025<br>Revision Incomplete<br>05 April 2025<br>Revised Manuscript Submitted<br>05 April 2025<br>With Journal Administrator<br>30 June 2025<br>Withdrawn, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Mon Jun 30 13:31:13 CST 2025, time=2025-06-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2271099, encodeId=addc22e109926, content=偏重的研究方向：临床研究<br>经验分享：杂志失联了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Fri Jun 27 13:24:26 CST 2025, time=2025-06-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2140147, encodeId=300c214014ee8, content=这个杂志查重放在哪一步啊目前处在修改格式的最初阶段🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Wed May 31 18:33:58 CST 2023, time=2023-05-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2219406, encodeId=6614221940646, content=偏重的研究方向：临床研究<br>经验分享：年刊中科院分区怎么算呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39e15555908, createdName=ms4000000190354659, createdTime=Sat Aug 10 17:09:45 CST 2024, time=2024-08-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220799, encodeId=53632220e99d0, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196b9426125, createdName=ms4000001726460894, createdTime=Sat Aug 17 13:31:35 CST 2024, time=2024-08-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究<br>经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2137722, encodeId=65b0213e72222, content=审稿速度:1.0<br>偏重的研究方向：感染<br>经验分享：当初通过Taylor & Francis Group投稿时杂志名称是 Annals of Medicine，但编辑后来发邮件修回时都显示的是“Annals of Medicine (Elevate)”，请问大家出现过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26ef8179690, createdName=ms7000001826758656, createdTime=Thu May 18 20:17:59 CST 2023, time=2023-05-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1241802, encodeId=f26f12418026c, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：第一次投这个期刊，感觉审稿速度很快，6月18号投，8月11号接到修改意见，23号就接收了，一切顺利的让人有些不可思议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fac5601213, createdName=ms1000000058940156, createdTime=Mon Aug 29 09:54:28 CST 2022, time=2022-08-29, status=1, ipAttribution=)]
    2024-08-17 ms4000001726460894 来自福建省

    不错

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2270543, encodeId=cddf22e0543a3, content=偏重的研究方向：回顾性分析;临床研究;内科学<br>经验分享：第一次投中科院二区，5分左右的期刊。 2024月10月投稿 一审历时三个月 2025年1月左右revision required,结果是小修 返修回去两天直接接受accepted,没有再继续二审 接受后大概再两个月后缴费并收到proof 返回proof后四天见刊。总体还算顺利，审稿人提的修改意见也都蛮专业，确实能提高文章质量 这个期刊主要是技术审查比较严格，在投稿、返修、接受后都会进行严格的审查(大概会花个一两天)，包括对文章文本和图片进行查重，以及对研究内容的伦理方面的审查等。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aeb9014890, createdName=ms5000000025670923, createdTime=Mon Jun 23 15:48:24 CST 2025, time=2025-06-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2249814, encodeId=d0012249814cf, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：一审45天：小修，二审10天：小修，三审3天：接受，出版时间：1月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1f8485059, createdName=ms4000002141710869, createdTime=Mon Jan 27 23:41:24 CST 2025, time=2025-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2271446, encodeId=b5b522e144686, content=非常垃圾的杂志，恶意拖拉稿件，回修后3个月没有任何反应，催稿就拒稿，绝对垃圾中的战斗机，我同事Proof交钱后一样给你撤稿。浪费你1-2年不在话下。26 November 2024<br>Submission Created<br>26 November 2024<br>Submission Incomplete<br>26 November 2024<br>Manuscript Submitted<br>26 November 2024<br>With Journal Administrator<br>27 November 2024<br>Submission Returned to Author<br>28 November 2024<br>Submission Incomplete<br>28 November 2024<br>Manuscript Resubmitted<br>28 November 2024<br>With Journal Administrator<br>06 December 2024<br>With Editor<br>30 January 2025<br>Out for Review<br>29 March 2025<br>Decision Pending<br>29 March 2025<br>Revision Required<br>05 April 2025<br>Revision Incomplete<br>05 April 2025<br>Revised Manuscript Submitted<br>05 April 2025<br>With Journal Administrator<br>30 June 2025<br>Withdrawn, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Mon Jun 30 13:31:13 CST 2025, time=2025-06-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2271099, encodeId=addc22e109926, content=偏重的研究方向：临床研究<br>经验分享：杂志失联了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Fri Jun 27 13:24:26 CST 2025, time=2025-06-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2140147, encodeId=300c214014ee8, content=这个杂志查重放在哪一步啊目前处在修改格式的最初阶段🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Wed May 31 18:33:58 CST 2023, time=2023-05-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2219406, encodeId=6614221940646, content=偏重的研究方向：临床研究<br>经验分享：年刊中科院分区怎么算呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39e15555908, createdName=ms4000000190354659, createdTime=Sat Aug 10 17:09:45 CST 2024, time=2024-08-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220799, encodeId=53632220e99d0, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196b9426125, createdName=ms4000001726460894, createdTime=Sat Aug 17 13:31:35 CST 2024, time=2024-08-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究<br>经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2137722, encodeId=65b0213e72222, content=审稿速度:1.0<br>偏重的研究方向：感染<br>经验分享：当初通过Taylor & Francis Group投稿时杂志名称是 Annals of Medicine，但编辑后来发邮件修回时都显示的是“Annals of Medicine (Elevate)”，请问大家出现过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26ef8179690, createdName=ms7000001826758656, createdTime=Thu May 18 20:17:59 CST 2023, time=2023-05-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1241802, encodeId=f26f12418026c, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：第一次投这个期刊，感觉审稿速度很快，6月18号投，8月11号接到修改意见，23号就接收了，一切顺利的让人有些不可思议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fac5601213, createdName=ms1000000058940156, createdTime=Mon Aug 29 09:54:28 CST 2022, time=2022-08-29, status=1, ipAttribution=)]
    2024-04-15 ms4000001908142028 来自浙江省

    偏重的研究方向：临床研究
    经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了

    13

    展开13条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2270543, encodeId=cddf22e0543a3, content=偏重的研究方向：回顾性分析;临床研究;内科学<br>经验分享：第一次投中科院二区，5分左右的期刊。 2024月10月投稿 一审历时三个月 2025年1月左右revision required,结果是小修 返修回去两天直接接受accepted,没有再继续二审 接受后大概再两个月后缴费并收到proof 返回proof后四天见刊。总体还算顺利，审稿人提的修改意见也都蛮专业，确实能提高文章质量 这个期刊主要是技术审查比较严格，在投稿、返修、接受后都会进行严格的审查(大概会花个一两天)，包括对文章文本和图片进行查重，以及对研究内容的伦理方面的审查等。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aeb9014890, createdName=ms5000000025670923, createdTime=Mon Jun 23 15:48:24 CST 2025, time=2025-06-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2249814, encodeId=d0012249814cf, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：一审45天：小修，二审10天：小修，三审3天：接受，出版时间：1月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1f8485059, createdName=ms4000002141710869, createdTime=Mon Jan 27 23:41:24 CST 2025, time=2025-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2271446, encodeId=b5b522e144686, content=非常垃圾的杂志，恶意拖拉稿件，回修后3个月没有任何反应，催稿就拒稿，绝对垃圾中的战斗机，我同事Proof交钱后一样给你撤稿。浪费你1-2年不在话下。26 November 2024<br>Submission Created<br>26 November 2024<br>Submission Incomplete<br>26 November 2024<br>Manuscript Submitted<br>26 November 2024<br>With Journal Administrator<br>27 November 2024<br>Submission Returned to Author<br>28 November 2024<br>Submission Incomplete<br>28 November 2024<br>Manuscript Resubmitted<br>28 November 2024<br>With Journal Administrator<br>06 December 2024<br>With Editor<br>30 January 2025<br>Out for Review<br>29 March 2025<br>Decision Pending<br>29 March 2025<br>Revision Required<br>05 April 2025<br>Revision Incomplete<br>05 April 2025<br>Revised Manuscript Submitted<br>05 April 2025<br>With Journal Administrator<br>30 June 2025<br>Withdrawn, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Mon Jun 30 13:31:13 CST 2025, time=2025-06-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2271099, encodeId=addc22e109926, content=偏重的研究方向：临床研究<br>经验分享：杂志失联了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Fri Jun 27 13:24:26 CST 2025, time=2025-06-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2140147, encodeId=300c214014ee8, content=这个杂志查重放在哪一步啊目前处在修改格式的最初阶段🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Wed May 31 18:33:58 CST 2023, time=2023-05-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2219406, encodeId=6614221940646, content=偏重的研究方向：临床研究<br>经验分享：年刊中科院分区怎么算呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39e15555908, createdName=ms4000000190354659, createdTime=Sat Aug 10 17:09:45 CST 2024, time=2024-08-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220799, encodeId=53632220e99d0, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196b9426125, createdName=ms4000001726460894, createdTime=Sat Aug 17 13:31:35 CST 2024, time=2024-08-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究<br>经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2137722, encodeId=65b0213e72222, content=审稿速度:1.0<br>偏重的研究方向：感染<br>经验分享：当初通过Taylor & Francis Group投稿时杂志名称是 Annals of Medicine，但编辑后来发邮件修回时都显示的是“Annals of Medicine (Elevate)”，请问大家出现过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26ef8179690, createdName=ms7000001826758656, createdTime=Thu May 18 20:17:59 CST 2023, time=2023-05-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1241802, encodeId=f26f12418026c, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：第一次投这个期刊，感觉审稿速度很快，6月18号投，8月11号接到修改意见，23号就接收了，一切顺利的让人有些不可思议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fac5601213, createdName=ms1000000058940156, createdTime=Mon Aug 29 09:54:28 CST 2022, time=2022-08-29, status=1, ipAttribution=)]
    2023-05-18 ms7000001826758656 来自安徽省

    审稿速度:1.0
    偏重的研究方向：感染
    经验分享：当初通过Taylor & Francis Group投稿时杂志名称是 Annals of Medicine，但编辑后来发邮件修回时都显示的是“Annals of Medicine (Elevate)”，请问大家出现过这种情况吗？

    7

    展开7条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2270543, encodeId=cddf22e0543a3, content=偏重的研究方向：回顾性分析;临床研究;内科学<br>经验分享：第一次投中科院二区，5分左右的期刊。 2024月10月投稿 一审历时三个月 2025年1月左右revision required,结果是小修 返修回去两天直接接受accepted,没有再继续二审 接受后大概再两个月后缴费并收到proof 返回proof后四天见刊。总体还算顺利，审稿人提的修改意见也都蛮专业，确实能提高文章质量 这个期刊主要是技术审查比较严格，在投稿、返修、接受后都会进行严格的审查(大概会花个一两天)，包括对文章文本和图片进行查重，以及对研究内容的伦理方面的审查等。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aeb9014890, createdName=ms5000000025670923, createdTime=Mon Jun 23 15:48:24 CST 2025, time=2025-06-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2249814, encodeId=d0012249814cf, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：一审45天：小修，二审10天：小修，三审3天：接受，出版时间：1月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1f8485059, createdName=ms4000002141710869, createdTime=Mon Jan 27 23:41:24 CST 2025, time=2025-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2271446, encodeId=b5b522e144686, content=非常垃圾的杂志，恶意拖拉稿件，回修后3个月没有任何反应，催稿就拒稿，绝对垃圾中的战斗机，我同事Proof交钱后一样给你撤稿。浪费你1-2年不在话下。26 November 2024<br>Submission Created<br>26 November 2024<br>Submission Incomplete<br>26 November 2024<br>Manuscript Submitted<br>26 November 2024<br>With Journal Administrator<br>27 November 2024<br>Submission Returned to Author<br>28 November 2024<br>Submission Incomplete<br>28 November 2024<br>Manuscript Resubmitted<br>28 November 2024<br>With Journal Administrator<br>06 December 2024<br>With Editor<br>30 January 2025<br>Out for Review<br>29 March 2025<br>Decision Pending<br>29 March 2025<br>Revision Required<br>05 April 2025<br>Revision Incomplete<br>05 April 2025<br>Revised Manuscript Submitted<br>05 April 2025<br>With Journal Administrator<br>30 June 2025<br>Withdrawn, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Mon Jun 30 13:31:13 CST 2025, time=2025-06-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2271099, encodeId=addc22e109926, content=偏重的研究方向：临床研究<br>经验分享：杂志失联了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Fri Jun 27 13:24:26 CST 2025, time=2025-06-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2140147, encodeId=300c214014ee8, content=这个杂志查重放在哪一步啊目前处在修改格式的最初阶段🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Wed May 31 18:33:58 CST 2023, time=2023-05-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2219406, encodeId=6614221940646, content=偏重的研究方向：临床研究<br>经验分享：年刊中科院分区怎么算呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39e15555908, createdName=ms4000000190354659, createdTime=Sat Aug 10 17:09:45 CST 2024, time=2024-08-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220799, encodeId=53632220e99d0, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196b9426125, createdName=ms4000001726460894, createdTime=Sat Aug 17 13:31:35 CST 2024, time=2024-08-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究<br>经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2137722, encodeId=65b0213e72222, content=审稿速度:1.0<br>偏重的研究方向：感染<br>经验分享：当初通过Taylor & Francis Group投稿时杂志名称是 Annals of Medicine，但编辑后来发邮件修回时都显示的是“Annals of Medicine (Elevate)”，请问大家出现过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26ef8179690, createdName=ms7000001826758656, createdTime=Thu May 18 20:17:59 CST 2023, time=2023-05-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1241802, encodeId=f26f12418026c, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：第一次投这个期刊，感觉审稿速度很快，6月18号投，8月11号接到修改意见，23号就接收了，一切顺利的让人有些不可思议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fac5601213, createdName=ms1000000058940156, createdTime=Mon Aug 29 09:54:28 CST 2022, time=2022-08-29, status=1, ipAttribution=)]
    2022-08-29 ms1000000058940156

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：内分泌
    经验分享：第一次投这个期刊，感觉审稿速度很快，6月18号投，8月11号接到修改意见，23号就接收了，一切顺利的让人有些不可思议。

    3

    展开3条回复
共500条页码: 1/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分